Carbaglu


What it is used for

Carbaglu is indicated in treatment of: Hyperammonaemia due to N-acetylglutamate synthase primary deficiency; – Hyperammonaemia due to Organic Acidaemias such as: Hyperammonaemia due to isovaleric acidaemia, Hyperammonaemia due to methymalonic acidaemia, Hyperammonaemia due to propionic acidaemia


How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

  • Store at 2 to 8 degrees Celsius
  • Refrigerate
  • Replace the cover firmly after use
  • Do not Freeze
  • Protect from Moisture
  • Protect from Light
  • Shelf lifetime is 30 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems


How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

  • Store at 2 to 8 degrees Celsius
  • Refrigerate
  • Replace the cover firmly after use
  • Do not Freeze
  • Protect from Moisture
  • Protect from Light
  • Shelf lifetime is 30 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Pregnant or planning a pregnancy?

For the active ingredient carglumic acid

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.


Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.


Visual appearance

A bar-shaped tablet, with 4 punches on one side (‘c c c c’), size 18.0 x 6.0 mm, with 3 break-marks both sides

0 0 votes
Do you use this medicine? Rate it:
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments